Discontinuation report MODULON

Last updated on 2019-02-01 History
Report ID 73450
Drug Identification Number 00803499
Brand name MODULON
Common or Proper name Modulon
Company Name APTALIS PHARMA CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) TRIMEBUTINE MALEATE
Strength(s) 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100's
ATC code A03AA
ATC description DRUGS FOR FUNCTIONAL BOWEL DISORDERS
Reason for discontinuation Other (Please describe in comments)
Anticipated discontinuation date 2019-01-31
Actual discontinuation date 2019-01-31
Remaining supply date 2019-01-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Stock run-out date = Jan 31st
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2019-02-01 English Compare
v2 2019-01-24 French Compare
v1 2019-01-24 English Compare

Showing 1 to 3 of 3